• Introduced
    Jan 14, 2025
  • Passed House
    Jun 03, 2026
  • Passed Senate
    Oct 20, 2026
  • Became Law
HB 69
Pennsylvania House Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
An Act amending the act of May 13, 2008 (P.L.139, No.14), known as the Cancer Drug Repository Program Act, further providing for title and short title of act, for definitions, for establishment, for restocking and dispensing of cancer drugs, for storage, distribution and fees and for immunity; providing for annual report, for list of approved participating pharmacies and for limitations; further providing for regulations; and imposing duties on the State Board of Pharmacy.
Last Action See all actions
House • Oct 21, 2026: Signed in House

Summary

Comments on HB 69

Tweets

Whip Lists

Sponsors
Votes
Actions
  • Oct 21, 2026 | House
    • Referred to Rules
    • Re-reported on concurrence, as committed
    • House concurred in Senate amendments
    • Signed in House
  • Oct 20, 2026 | Senate
    • Third consideration and final passage
  • Oct 19, 2026 | Senate
    • Re-reported as amended
  • Jun 25, 2026 | Senate
    • Second consideration
    • Re-referred to Appropriations
  • Jun 24, 2026 | Senate
    • Reported as committed
    • First consideration
  • Jun 05, 2026 | Senate
    • Referred to Health & Human Services
  • Jun 03, 2026 | House
    • Re-reported as committed
    • Third consideration and final passage
  • Jun 02, 2026 | House
    • Second consideration, with amendments
    • Re-committed to Appropriations
  • Jun 01, 2026 | House
    • Removed from table
  • Apr 09, 2025 | House
    • Reported as amended
    • First consideration
    • Laid on the table
  • Jan 14, 2025 | House
    • Referred to Health
Bill Texts